Recent Research Analysts’ Ratings Updates for Rocket Lab (RKLB)
A number of firms have modified their ratings and price targets on shares of Rocket Lab (NASDAQ: RKLB) recently: 7/17/2026 – Rocket Lab had its “sell (d-)” rating reaffirmed by Weiss Ratings. 7/15/2026 – Rocket Lab is now covered by Piper Sandler. They set a “neutral” rating and a $83.00 price target on the stock. […]
Recent Analysts’ Ratings Updates for Albemarle (ALB)
Several brokerages have updated their recommendations and price targets on shares of Albemarle (NYSE: ALB) in the last few weeks: 7/20/2026 – Albemarle was downgraded by Zacks Research from “strong-buy” to “hold”. 7/20/2026 – Albemarle had its price target lowered by Truist Financial Corporation from $260.00 to $245.00. They now have a “buy” rating on […]
Recent Research Analysts’ Ratings Updates for JFrog (FROG)
JFrog (NASDAQ: FROG) recently received a number of ratings updates from brokerages and research firms: 7/22/2026 – JFrog had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. 7/22/2026 – JFrog was given a new $80.00 price target by Raymond James Financial, Inc.. 7/22/2026 – JFrog had its “outperform” rating reaffirmed by Oppenheimer Holdings, Inc.. […]
Recent Analysts’ Ratings Updates for Moelis & Company (MC)
Several brokerages have updated their recommendations and price targets on shares of Moelis & Company (NYSE: MC) in the last few weeks: 7/14/2026 – Moelis & Company was upgraded by Zacks Research from “strong sell” to “hold”. 7/10/2026 – Moelis & Company had its price target lowered by Keefe, Bruyette & Woods from $69.00 to […]
Analysts’ Recent Ratings Updates for WhiteHawk Income (WHK)
WhiteHawk Income (NYSE: WHK) recently received a number of ratings updates from brokerages and research firms: 7/7/2026 – WhiteHawk Income was upgraded by Zacks Research to “hold”. 7/7/2026 – WhiteHawk Income is now covered by Raymond James Financial, Inc.. They set a “strong-buy” rating and a $34.00 price target on the stock. 7/6/2026 – WhiteHawk […]
Recent Analysts’ Ratings Updates for Wingstop (WING)
A number of firms have modified their ratings and price targets on shares of Wingstop (NASDAQ: WING) recently: 7/16/2026 – Wingstop had its price target lowered by Wells Fargo & Company from $200.00 to $170.00. They now have an “overweight” rating on the stock. 7/14/2026 – Wingstop had its “neutral” rating reaffirmed by UBS Group […]
Avantor (AVTR) – Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Avantor (NYSE: AVTR): 7/15/2026 – Avantor had its “hold” rating reaffirmed by TD Cowen. 7/8/2026 – Avantor had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a “neutral” rating on the stock. 7/6/2026 – Avantor was […]
Analysts’ Recent Ratings Updates for Globus Medical (GMED)
A number of research firms have changed their ratings and price targets for Globus Medical (NYSE: GMED): 7/16/2026 – Globus Medical had its price target lowered by Truist Financial Corporation from $115.00 to $100.00. They now have a “buy” rating on the stock. 7/13/2026 – Globus Medical had its “hold (c+)” rating reaffirmed by Weiss […]
Equity Lifestyle Properties (ELS) – Research Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Equity Lifestyle Properties (NYSE: ELS): 7/14/2026 – Equity Lifestyle Properties had its “equal weight” rating reaffirmed by Barclays PLC. They now have a $68.00 price target on the stock. 7/9/2026 – Equity Lifestyle Properties was given a new $65.00 price target by […]
Newmont (NEM) – Research Analysts’ Recent Ratings Updates
Newmont (NYSE: NEM) recently received a number of ratings updates from brokerages and research firms: 7/15/2026 – Newmont had its price target lowered by Barclays PLC from $133.00 to $125.00. They now have an “overweight” rating on the stock. 7/15/2026 – Newmont had its “positive” rating reaffirmed by Citigroup Inc.. 7/14/2026 – Newmont was downgraded […]
Recent Research Analysts’ Ratings Updates for Rio Tinto Group (RIO)
Rio Tinto Group (LON: RIO) recently received a number of ratings updates from brokerages and research firms: 7/16/2026 – Rio Tinto Group had its price target lowered by Berenberg Bank from GBX 8,200 to GBX 8,100. They now have a “hold” rating on the stock. 7/16/2026 – Rio Tinto Group had its price target lowered […]
Voya Financial (VOYA) – Research Analysts’ Recent Ratings Updates
Several analysts have recently updated their ratings and price targets for Voya Financial (NYSE: VOYA): 7/15/2026 – Voya Financial was given a new $79.00 price target by Atlantic Securities. 7/13/2026 – Voya Financial had its price target raised by Keefe, Bruyette & Woods from $92.00 to $109.00. They now have an “outperform” rating on the […]
Recent Research Analysts’ Ratings Updates for Zoetis (ZTS)
Several analysts have recently updated their ratings and price targets for Zoetis (NYSE: ZTS): 7/6/2026 – Zoetis had its price target lowered by HSBC Holdings plc from $140.00 to $95.00. They now have a “buy” rating on the stock. 7/1/2026 – Zoetis had its price target lowered by Barclays PLC from $136.00 to $85.00. They […]
Recent Research Analysts’ Ratings Updates for Fidelis Insurance (PLGO)
Several brokerages have updated their recommendations and price targets on shares of Fidelis Insurance (NYSE: PLGO) in the last few weeks: 7/10/2026 – Fidelis Insurance had its price target raised by Citizens Jmp from $27.00 to $28.00. They now have a “market outperform” rating on the stock. 7/8/2026 – Fidelis Insurance had its price target […]
Regal Rexnord (RRX) – Analysts’ Recent Ratings Updates
A number of firms have modified their ratings and price targets on shares of Regal Rexnord (NYSE: RRX) recently: 7/14/2026 – Regal Rexnord had its price target raised by Citigroup Inc. from $240.00 to $260.00. They now have a “buy” rating on the stock. 7/10/2026 – Regal Rexnord had its “outperform” rating reaffirmed by Oppenheimer […]
Analysts’ Recent Ratings Updates for Sharplink Gaming (SBET)
Sharplink Gaming (NASDAQ: SBET) recently received a number of ratings updates from brokerages and research firms: 7/12/2026 – Sharplink Gaming was upgraded by Wall Street Zen from “sell” to “hold”. 7/9/2026 – Sharplink Gaming had its “market outperform” rating reaffirmed by Citigroup Inc.. 7/9/2026 – Sharplink Gaming had its price target lowered by Citizens Jmp […]
BeOne Medicines (ONC) – Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for BeOne Medicines (NASDAQ: ONC): 7/14/2026 – BeOne Medicines had its price target lowered by Barclays PLC from $409.00 to $403.00. They now have an “overweight” rating on the stock. 7/7/2026 – BeOne Medicines had its price target raised by Royal Bank Of […]
Recent Analysts’ Ratings Updates for Bandwidth (BAND)
A number of research firms have changed their ratings and price targets for Bandwidth (NASDAQ: BAND): 7/9/2026 – Bandwidth had its price target raised by B. Riley Financial, Inc. from $55.00 to $85.00. They now have a “buy” rating on the stock. 7/3/2026 – Bandwidth was downgraded by Zacks Research from “strong-buy” to “hold”. 6/28/2026 […]
Analysts’ Recent Ratings Updates for Merck & Co., Inc. (MRK)
A number of research firms have changed their ratings and price targets for Merck & Co., Inc. (NYSE: MRK): 7/9/2026 – Merck & Co., Inc. had its price target raised by Morgan Stanley from $112.00 to $113.00. They now have an “equal weight” rating on the stock. 7/8/2026 – Merck & Co., Inc. had its […]
Research Analysts’ Recent Ratings Updates for Columbia Banking System (COLB)
Columbia Banking System (NASDAQ: COLB) recently received a number of ratings updates from brokerages and research firms: 7/6/2026 – Columbia Banking System had its price target raised by Wells Fargo & Company from $30.00 to $32.00. They now have an “equal weight” rating on the stock. 7/1/2026 – Columbia Banking System was given a new […]
Analysts’ Recent Ratings Updates for 10x Genomics (TXG)
A number of firms have modified their ratings and price targets on shares of 10x Genomics (NASDAQ: TXG) recently: 7/9/2026 – 10x Genomics had its price target raised by Morgan Stanley from $22.00 to $37.00. They now have an “equal weight” rating on the stock. 7/8/2026 – 10x Genomics had its price target raised by […]
Analysts’ Recent Ratings Updates for Parabilis Medicines (PBLS)
A number of research firms have changed their ratings and price targets for Parabilis Medicines (NASDAQ: PBLS): 7/7/2026 – Parabilis Medicines was upgraded by Zacks Research to “hold”. 7/6/2026 – Parabilis Medicines is now covered by Guggenheim. They set a “buy” rating and a $40.00 price target on the stock. 7/6/2026 – Parabilis Medicines was […]
last updated on 23 Jul 02:35